
Somnoware provides a cloud-based software platform for the sleep and respiratory care industry, aiming to streamline diagnostic testing workflows and automate care management processes. Their platform, Somnoware Diagnostics, integrates disparate devices and data from third-party applications, minimizing toggling between systems and consolidating patient data. Key features include EHR integration, automated patient charting via HL7, digital questionnaires, simplified scheduling with SMS notifications, device inventory management for home sleep testing, and one-click DME order generation. The platform is FedRAMP authorized and SOC 2 compliant, ensuring data security. Somnoware helps healthcare providers unify data, streamline operations, and improve patient engagement, with over 800 facilities reportedly using their solution.

Somnoware provides a cloud-based software platform for the sleep and respiratory care industry, aiming to streamline diagnostic testing workflows and automate care management processes. Their platform, Somnoware Diagnostics, integrates disparate devices and data from third-party applications, minimizing toggling between systems and consolidating patient data. Key features include EHR integration, automated patient charting via HL7, digital questionnaires, simplified scheduling with SMS notifications, device inventory management for home sleep testing, and one-click DME order generation. The platform is FedRAMP authorized and SOC 2 compliant, ensuring data security. Somnoware helps healthcare providers unify data, streamline operations, and improve patient engagement, with over 800 facilities reportedly using their solution.
Product: Cloud-based platform for sleep and respiratory diagnostic workflows and care management
Security / Compliance: FedRAMP authorized and SOC 2 compliant
Acquisition: Acquired by ResMed (announced July 5, 2023)
Customers: Used by over 800 facilities (reported)
Founding year: 2011
Workflow orchestration and data integration for sleep and respiratory diagnostic testing and care management.
2011
Healthtech / Medical Software
Most recent funding listed as a convertible note on May 12, 2022
“CerraCap Ventures and Translink Capital listed among investors; acquired by ResMed (announced July 5, 2023)”